Sequential JAK inhibition enhances antitumor immunity after combined anti–PD-1 and anti-CTLA4Marcel Arias-Badia, Lawrence Fong, Aram Lyu et al.|JCI Insight|2025Cited by 4
674 Multi-omic single-cell assessment of castration-resistant prostate cancer patients receiving ¹ <sup>7</sup> <sup>7</sup> Lu-PSMA-617 and pembrolizumab shows timing of radioligand therapy alters immune responseAnusha Muralidhar, Lawrence Fong, Karen Law et al.|Regular and Young Investigator Award Abstracts|2025Cited by 0